"10.1371_journal.pone.0143719","plos one","2015-11-30T00:00:00Z","Francesco Infarinato; Anisur Rahman; Claudio Del Percio; Yves Lamberty; Regis Bordet; Jill C Richardson; Gianluigi Forloni; Wilhelmus Drinkenburg; Susanna Lopez; Fabienne Aujard; Claudio Babiloni; Fabien Pifferi; IMI project \"PharmaCog\" Consortium","IRCCS San Raffaele Pisana, Rome, Italy; UMR 7179 Centre National de la Recherche Scientifique, Muséum National dHistoire Naturelle, Brunoy, France; IRCCS SDN, Naples, Italy; UCB Pharma s.a., Neuroscience Therapeutic Area, Braine lAlleud, Belgium; LUniversité Lille 2 Droit et Santé, Lille, France; Neurosciences Therapeutic Area Unit, GlaxoSmithKline R&D, Gunnels Wood Road, Stevenage, United Kingdom; Department of Neurodegeneration, Mario Negri Institute, Milan, Italy; Janssen Research & Development, Turnhoutsewe, Beerse, Belgium; Department of Physiology and Pharmacology, University of Rome La Sapienza, Rome, Italy","Conceived and designed the experiments: RB JCR FA CB FP. Performed the experiments: AR FA FP. Analyzed the data: FI CDP SL. Contributed reagents/materials/analysis tools: FI AR CDP YL GF WD SL FP. Wrote the paper: FI AR CDP YL RB JCR GF WD SL FA CB FP.","None of the authors has conflicts of interest or financial disclosures in the development of the present precompetitive basic neurophysiological research, which was based on EEG recordings in freely behaving mouse lemurs receiving no (pharmacological or non-pharmacological) intervention. This is true also for the following co-Authors: Dr. Yves Lamberty, Jill Richardson and Wilhelmus Drinkenburg, who are affiliated to UCB Pharma, Glaxo SmithKline and Janssen Pharmaceutica, respectively. Their position to the mentioned companies does not alter the authors adherence to the PLOS ONE policies on sharing data and materials.","2015","11","Francesco Infarinato","FI",13,TRUE,5,3,3,12,TRUE,TRUE,TRUE,1,"13",TRUE
